TAILIN BIOTECH(SZ:300813) Zheng Quan Zhi Xing·2025-07-16 04:10Overview - The announcement details the completion of a share transfer agreement between the controlling shareholders of Zhejiang Tailin Biological Technology Co., Ltd, specifically between Mr. Ye Dalin and Ms. Ni Weijun, involving 12,100,000 shares, which represents 9.9836% of the company's total share capital [1][9]. Share Transfer Details - The share transfer was executed through an internal agreement and does not involve any reduction in the secondary market, ensuring that the total shareholding of Mr. Ye Dalin and Ms. Ni Weijun remains unchanged [1][9]. - The share transfer agreement was signed on May 30, 2025, and the transfer was completed on July 15, 2025 [1][7]. Financial Terms - The transfer price was set at RMB 15.216 per share, totaling RMB 184,113,600 (approximately 184.11 million) [3][5]. - Payment for the shares is to be completed within one year following the transfer [3][5]. Shareholder Commitments - Ms. Ni Weijun has committed not to reduce her holdings from this transfer for a period of 12 months following the completion of the transfer [2][9]. - Both parties have confirmed that the transfer does not affect the company's financial status or the interests of minority investors [1][9]. Regulatory Compliance - The transfer has been confirmed as compliant with relevant regulations, and necessary documentation has been submitted to the Shenzhen Stock Exchange [4][8].